🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Genitourinary Cancer

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study NCT06855706NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Behavioral Intervention, Best Practice, Biospecimen Collection, Electronic Health Record Review, Exercise Intervention Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy NCT05903833Phase 215 sites📍 Augsburg📍 Bad Homburg📍 Dresden AGO Research GmbH · Tests: Pembrolizumab, Lenvatinib BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) NCT04752826Phase 1, Phase 225 sites📍 Duarte📍 New York📍 Philadelphia BioInvent International AB · Tests: BI-1808, Pembrolizumab (KEYTRUDA® ) 25 Mg/mL Solution for Injection, Paclitaxel 80 mg/m2 weekly Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors NCT05797168Phase 1, Phase 260 sites📍 Duarte📍 Irvine📍 La Jolla AstraZeneca · Tests: Torvutatug samrotecan, Saruparib, Bevacizumab, Carboplatin, Palacaparib MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies NCT07064018Phase 1, Phase 21 site📍 Orange University of California, Irvine · Tests: Spedox-6, Pegfilgrastim, Filgrastim Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors NCT07106814EARLY Phase 11 site📍 Hefei Anhui Provincial Hospital · Tests: Metabolically Armed TIL cells Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) NCT06218433NA2 sites📍 Vancouver📍 Tampere Tampere University Hospital · Tests: Urothelial cancer screening using urine tumor DNA test, Urothelial cancer screening using urine cytology (comparator) High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins NCT06835426NA1 site📍 Ghent Algemeen Ziekenhuis Maria Middelares · Tests: Single intravenous injection of the radiotracer, Imaging resected specimen using the high-resolution PET-CT specimen im… Evaluating Tolerability of ePUHRT With Brachytherapy Boost NCT06817668NA1 site📍 Indianapolis Indiana University · Tests: ePURT 5Gy x 5 fractions with single HDR boost of 15Gy Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer NCT06684652NA1 site📍 Beijing Peking University First Hospital · Tests: 3TB+6SB, 3TB+12SB Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort NCT05384535NA1 site📍 Lake Success Northwell Health · Tests: Bi-parametric MRI Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome NCT06155708NA1 site📍 Montreal McGill University · Tests: Ketone, Water Molecular and ctDNA Characterization of High-Risk Endometrial Cancer NCT07062016n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study Systems Oncology Approach to Optimize Ovarian Cancer Treatment NCT06117384n/a1 site📍 Helsinki University of Helsinki · Tests: Biomolecular profiling Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) NCT07427043Phase 32 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: multimodal analgesia pathway with up-front small opioid prescription, multimodal analgesia pathway without up-front sma… A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site📍 Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. · Tests: Autologous tumor infiltrating lymphocytes (TILs) Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM) NCT07034976NA1 site📍 Madrid Fundacion para la Investigacion Biomedica del Hospital Univ… · Tests: Active Radiofrequency (Capenergy C500 UpGradeC200), Sham Radiofrequency (Capenergy C500 UpGrade C200 - Placebo Mode) Ovarian Cancer Radiomics Approach in CT Led Evaluation NCT06817174n/a1 site📍 London Imperial College Healthcare NHS Trust A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer NCT05327647Phase 27 sites📍 London📍 Toronto📍 Lévis CHU de Quebec-Universite Laval · Tests: Bicalutamide, Control Arm Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer NCT06640348n/a1 site📍 Hefei Anhui Provincial Hospital · Tests: No intervention Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection NCT05413850Phase 1, Phase 221 sites📍 Miami📍 Miami📍 Atlanta Blue Earth Therapeutics Ltd · Tests: Lutetium (177Lu) rhPSMA-10.1 Injection, 18F-rhPSMA-7.3 injection (in phase 1 only) Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS NCT06793904NA1 site📍 Cairo Cairo University · Tests: Aromatase inhibitor Letrozole Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment NCT07118813n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… [18F]FES PET/.CT in Uterine Cancer NCT05916196Phase 21 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: 18F-Fluoroestradiol Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India NCT07290972n/a2 sites📍 Mumbai📍 Mumbai Tata Memorial Hospital · Tests: Not applicable- observational study The Women's Screening and Self-Testing Program (PROMETA) Study NCT06810739NA1 site📍 Maputo Tulane University · Tests: HPV DNA testing be self-collected vaginal swab Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer NCT04823923NA5 sites📍 Marseille📍 Montpellier📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: blood sampling for ITK dosage Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine. NCT06394869NA20 sites📍 Homewood📍 Mobile📍 Fresno Pacific Edge Limited · Tests: Cxbladder Triage Plus PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer NCT07472153Phase 2, Phase 31 site📍 Minsk N.N. Alexandrov National Cancer Centre · Tests: PD-1 antibody, PD-L1 antibody, Chemotherapy and bevacizumab (CT-BEV)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy